August 2009 news about us

Articles that mention MVI

Profectus BioSciences receives funding for malaria vaccine research
August 25, 2009 – Profectus BioSciences, Inc., a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announces a research collaboration to accelerate malaria vaccine development.
Profectus BioSciences website

On the ground in Uganda and Tanzania
August 21, 2009 – The ONE Campaign guest blogger, Gabrielle Fitzgerald of the Bill and Melinda Gates Foundation is on the ground in Tanzania with Dr. Margaret Chan, Mr. Ray Chambers, and Dr. Tachi Yamada. She reports back on their visit to the Bagamoyo Research and Training Center of the Ifakara Health Institute. Underway at Bagamoyo, is the Phase 3 trial of the RTS,S vaccine candidate in partnership with MVI and GSK.
The One Campaign